|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0032207,
umls-concept:C0038952,
umls-concept:C0040808,
umls-concept:C0045093,
umls-concept:C0205179,
umls-concept:C0332256,
umls-concept:C0684249,
umls-concept:C0920317,
umls-concept:C1274040,
umls-concept:C1707455
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-17
|
|
pubmed:abstractText |
Gemcitabine-platinum combination activity has been clearly established in a number of phase II studies. It has also been compared against other combinations in many phase III trials. It is generally believed that all such regimens have an equivalent impact on survival. This meta-analysis aims to quantify the treatment effect of gemcitabine plus a platinum agent in the treatment of advanced NSCLC and compare the combination to other regimens used globally.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:AristidesMM,
pubmed-author:BrownAA,
pubmed-author:CrinoLL,
pubmed-author:DansonSS,
pubmed-author:FitzgeraldPP,
pubmed-author:GridelliCC,
pubmed-author:Le ChevalierTT,
pubmed-author:ManegoldCC,
pubmed-author:NataleRR,
pubmed-author:PujolJ-LJL,
pubmed-author:RosellRR,
pubmed-author:RuddR MRM,
pubmed-author:ScagliottiGG,
pubmed-author:SchillerJ HJH,
pubmed-author:StahelRR,
pubmed-author:ThatcherNN,
pubmed-author:ThomasPP,
pubmed-author:VansteenkisteJJ,
pubmed-author:van MeerbeeckJ PJP,
pubmed-author:van ZandwijkNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
69-80
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15603856-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15603856-Carboplatin,
pubmed-meshheading:15603856-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15603856-Cisplatin,
pubmed-meshheading:15603856-Deoxycytidine,
pubmed-meshheading:15603856-Disease Progression,
pubmed-meshheading:15603856-Disease-Free Survival,
pubmed-meshheading:15603856-Humans,
pubmed-meshheading:15603856-Lung Neoplasms,
pubmed-meshheading:15603856-Randomized Controlled Trials as Topic,
pubmed-meshheading:15603856-Risk Factors,
pubmed-meshheading:15603856-Survival Analysis,
pubmed-meshheading:15603856-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
|
|
pubmed:affiliation |
Institute Gustave-Roussy, 39-53 Rue Camille Desmoulins, F-94800 Villejuif, France. tle-che@igr.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
